Crotylbarbital
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Systematic (IUPAC) name | |
---|---|
5-but-2-enyl-5-ethyl-1,3-diazinane-2,4,6-trione
|
|
Identifiers | |
CAS Number | 1952-67-6 ![]() |
ATC code | none |
PubChem | CID 5364821 |
ChemSpider | 4516954 ![]() |
Chemical data | |
Formula | C10H14N2O3 |
Molar mass | 210.23 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Crotylbarbital (Mepertan, Kalipnon, Barotal), also known as crotarbital, is a barbiturate derivative developed by Eli Lilly in the 1930s[1]m It has sedative and hypnotic effects,[2] and was used for the treatment of insomnia until it was replaced by newer alternative drugs with less side effects and lower risk of overdose.
See also[edit]
References[edit]
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics
|
![]() |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |